No Data
No Data
Leerink Partners Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Announces Target Price $8
Analysts Offer Insights on Healthcare Companies: Arvinas Holding Company (ARVN), Eledon Pharmaceuticals (ELDN) and Arcutis Biotherapeutics (ARQT)
Analysts Are Bullish on These Healthcare Stocks: Biomea Fusion (BMEA), Eledon Pharmaceuticals (ELDN)
Guggenheim Remains a Buy on Eledon Pharmaceuticals (ELDN)
We're Hopeful That Eledon Pharmaceuticals (NASDAQ:ELDN) Will Use Its Cash Wisely
H.C. Wainwright Maintains Eledon Pharmaceuticals(ELDN.US) With Buy Rating, Maintains Target Price $16